Protocol
UC
DISEASE
Each patient was evaluated by the one of the study investigators to determine their disease activity and clinical inactivity (HBI <5 for CD or modified HBI <5 for UC). After completing the first research visit, all participants were then asked to take their AZA or 6-MP at the opposite time of day from their baseline (either between 6 